ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

NIC Grants Appeals Process Explained

April 19, 1985

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA.

May 26, 2000

Waxman Compromise Bill Clears House; Centers Line Item Traded For Guarantee Of Minimum Number of 55

November 25, 1983

DCPC Begins Reassessment of Year 2000 Goals; Advisors Discuss A ‘More Dynamic Model’

May 22, 1992

In Brief: Wynder Receives ACS Award At ASCO; Brinker to Be Honored for Public Service

May 23, 1997